Stay updated on Pembrolizumab and Lenvatinib in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added revision tag v3.5.0 and removed revision tag v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T21:00:12.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.2 to v3.4.3. No user-facing content or functionality changes.
    Difference
    0.0%
    Check dated 2026-03-11T20:02:58.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Added Plain Language Summary and data-sharing links (Trialstransparency PDF, externaldatasharing-msd). Removed older EngageZone data-sharing documents and updated revision to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-11T10:25:22.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed Revision: v3.4.0; this appears to be revision metadata only. No study content such as eligibility criteria, locations, or outcomes has changed.
    Difference
    0.0%
    Check dated 2026-02-04T10:13:12.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Added: Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-28T05:41:47.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.3.3 to v3.3.4; no content changes to the study details or documents are apparent. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:00:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Lenvatinib in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page.